Dihydrolipoic acid is an organic compound that is the reduced form of lipoic acid. This carboxylic acid features a pair of thiol groups, and therefore is a dithiol. It is optically active, but only the R-enantiomer is biochemically significant. The lipoic acid/dihydrolipoic acid pair participate in a variety of biochemical transformations. |
Read full article at Wikipedia
|
InChI=1S/C23H34O5/c1- 4- 14(2) 23(26) 28- 20- 7- 5- 6- 16- 9- 8- 15(3) 19(22(16) 20) 11- 10- 18- 12- 17(24) 13- 21(25) 27- 18/h6,8- 9,14- 15,17- 20,22,24H,4- 5,7,10- 13H2,1- 3H3/t14- ,15- ,17+,18+,19- ,20- ,22- /m0/s1 |
AJLFOPYRIVGYMJ-INTXDZFKSA-N |
CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 |
|
fungal metabolite
Any eukaryotic metabolite produced during a metabolic reaction in fungi, the kingdom that includes microorganisms such as the yeasts and moulds.
EC 3.4.24.83 (anthrax lethal factor endopeptidase) inhibitor
An EC 3.4.24.* (metalloendopeptidase) inhibitor that interferes with the action of anthrax lethal factor endopeptidase (EC 3.4.24.83).
antifungal agent
An antimicrobial agent that destroys fungi by suppressing their ability to grow or reproduce.
Penicillium metabolite
Any fungal metabolite produced during a metabolic reaction in Penicillium.
apoptosis inducer
Any substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms.
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via statin (naturally occurring) )
EC 1.1.1.34/EC 1.1.1.88 (hydroxymethylglutaryl-CoA reductase) inhibitor
Any EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD+ or NADP+ acceptor) inhibitor that inhibits HMG-CoA reductases. Hydroxymethylglutaryl-CoA reductase inhibitors have been shown to lower directly cholesterol synthesis. The Enzyme Commission designation is EC 1.1.1.34 for the NADPH-dependent enzyme and EC 1.1.1.88 for an NADH-dependent enzyme.
(via statin )
|
|
anticholesteremic drug
A substance used to lower plasma cholesterol levels.
(via statin )
|
|
View more via ChEBI Ontology
(1S,7S,8S,8aR)- 8- {2- [(2R,4R)- 4- hydroxy- 6- oxotetrahydro- 2H- pyran- 2- yl]ethyl}- 7- methyl- 1,2,3,7,8,8a- hexahydronaphthalen- 1- yl (2S)- 2- methylbutanoate
|
mevastatin
|
WHO MedNet
|
mevastatina
|
WHO MedNet
|
mévastatine
|
WHO MedNet
|
mevastatinum
|
WHO MedNet
|
antibiotic ML 236B
|
ChemIDplus
|
Compactin
|
KEGG COMPOUND
|
CS 500
|
ChemIDplus
|
mevastatin
|
UniProt
|
Mevastatin
|
KEGG COMPOUND
|
ML 236 B
|
ChemIDplus
|
ML-236B
|
KEGG COMPOUND
|
3630717
|
Reaxys Registry Number
|
Reaxys
|
73573-88-3
|
CAS Registry Number
|
ChemIDplus
|
11283400
|
PubMed citation
|
Europe PMC
|
12403272
|
PubMed citation
|
Europe PMC
|
15274361
|
PubMed citation
|
Europe PMC
|
15531285
|
PubMed citation
|
Europe PMC
|
15786722
|
PubMed citation
|
Europe PMC
|
18672387
|
PubMed citation
|
Europe PMC
|
18936176
|
PubMed citation
|
Europe PMC
|
20629200
|
PubMed citation
|
Europe PMC
|
23918904
|
PubMed citation
|
Europe PMC
|
24462564
|
PubMed citation
|
Europe PMC
|
3170348
|
PubMed citation
|
Europe PMC
|
3719857
|
PubMed citation
|
Europe PMC
|
|